| scholarly article | Q13442814 |
| P2093 | author name string | D Maurice | |
| L Roux | |||
| C Tapparel | |||
| P2860 | cites work | Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited | Q24531423 |
| The Sendai virus P gene expresses both an essential protein and an inhibitor of RNA synthesis by shuffling modules via mRNA editing | Q24564716 | ||
| Visualization of protein-nucleic acid interactions in a virus. Refined structure of intact tobacco mosaic virus at 2.9 A resolution by X-ray fiber diffraction | Q27728170 | ||
| Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase | Q27860943 | ||
| Scanning independent ribosomal initiation of the Sendai virus Y proteins in vitro and in vivo | Q33559628 | ||
| Vesicular stomatitis virus defective interfering particle containing a muted internal leader RNA gene | Q35341067 | ||
| Extent of terminal complementarity modulates the balance between transcription and replication of vesicular stomatitis virus RNA. | Q35733629 | ||
| Sequence variability and function of measles virus 3′ and 5′ ends and intercistronic regions | Q36451577 | ||
| Inhibition of Sendai virus genome replication due to promoter-increased selectivity: a possible role for the accessory C proteins | Q36549060 | ||
| Rescue of synthetic analogs of genomic RNA and replicative-intermediate RNA of human parainfluenza virus type 3. | Q36645648 | ||
| The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. | Q36651219 | ||
| Modified model for the switch from Sendai virus transcription to replication. | Q36827224 | ||
| The Sendai virus nucleocapsid exists in at least four different helical states | Q36827521 | ||
| Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide | Q37434689 | ||
| Rescue of synthetic analogs of respiratory syncytial virus genomic RNA and effect of truncations and mutations on the expression of a foreign reporter gene | Q37611890 | ||
| Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3' proximal first locus | Q38555148 | ||
| Functional cDNA clones of the human respiratory syncytial (RS) virus N, P, and L proteins support replication of RS virus genomic RNA analogs and define minimal trans-acting requirements for RNA replication. | Q39869698 | ||
| Further characterization of sendai virus DI-RNAs: A model for their generation | Q40105287 | ||
| A specific internal RNA polymerase recognition site of VSV RNA is involved in the generation of DI particles | Q40279849 | ||
| Sequence of 3,687 nucleotides from the 3' end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P and C proteins | Q40494302 | ||
| Determination of the complete nucleotide sequence of the Sendai virus genome RNA and the predicted amino acid sequences of the F, HN and L proteins | Q40560159 | ||
| Genetic manipulation of non-segmented negative-strand RNA viruses | Q40970649 | ||
| Replication signals in the genome of vesicular stomatitis virus and its defective interfering particles: identification of a sequence element that enhances DI RNA replication. | Q41105473 | ||
| The efficiency of Sendai virus genome replication: the importance of the RNA primary sequence independent of terminal complementarity | Q41154577 | ||
| A Sendai virus vector leading to the efficient expression of mutant M proteins interfering with virus particle budding | Q41190231 | ||
| Rescue of synthetic measles virus minireplicons: measles genomic termini direct efficient expression and propagation of a reporter gene | Q41349446 | ||
| Rescue of a 7502-nucleotide (49.3% of full-length) synthetic analog of respiratory syncytial virus genomic RNA. | Q41545368 | ||
| Molecular cloning of natural paramyxovirus copy-back defective interfering RNAs and their expression from DNA. | Q42600279 | ||
| Sendai virus NP gene codes for a 524 amino acid NP protein | Q42621912 | ||
| Functional Characterisation of the Genomic and Antigenomic Promoters of Sendai Virus | Q44081044 | ||
| The Sendai virus nonstructural C proteins specifically inhibit viral mRNA synthesis | Q45140859 | ||
| Increased expression of the N protein of respiratory syncytial virus stimulates minigenome replication but does not alter the balance between the synthesis of mRNA and antigenome | Q45760504 | ||
| Partial characterization of a Sendai virus replication promoter and the rule of six. | Q45767226 | ||
| Molecular cloning and characterization of a Sendai virus internal deletion defective RNA. | Q45775801 | ||
| Defective measles virus in human subacute sclerosing panencephalitis brain | Q45781281 | ||
| N protein of vesicular stomatitis virus selectively encapsidates leader RNA in vitro | Q45798966 | ||
| The tobacco mosaic virus assembly origin RNA. Functional characteristics defined by directed mutagenesis | Q45833249 | ||
| A measles virus subgenomic RNA: structure and generation mechanism | Q45843225 | ||
| Sendai virus P gene produces multiple proteins from overlapping open reading frames | Q45853675 | ||
| The molecular biology of paramyxoviruses. | Q53782378 | ||
| Interaction of VSV leader RNA and nucleocapsid protein may control VSV genome replication | Q72890370 | ||
| P433 | issue | 4 | |
| P921 | main subject | Sendai virus | Q1055751 |
| P304 | page(s) | 3117-3128 | |
| P577 | publication date | 1998-04-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | The activity of Sendai virus genomic and antigenomic promoters requires a second element past the leader template regions: a motif (GNNNNN)3 is essential for replication | |
| P478 | volume | 72 |
| Q24529099 | "Rule of six": how does the Sendai virus RNA polymerase keep count? |
| Q38717196 | A Point Mutation in the RNA-Binding Domain of Human Parainfluenza Virus Type 2 Nucleoprotein Elicits Abnormally Enhanced Polymerase Activity |
| Q45411131 | A comparison of complete untranslated regions of measles virus genomes derived from wild-type viruses and SSPE brain tissues |
| Q43106551 | A recombinant, infectious human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assays |
| Q34365261 | Ambisense sendai viruses are inherently unstable but are useful to study viral RNA synthesis |
| Q40578904 | An internal element of the measles virus antigenome promoter modulates replication efficiency |
| Q35302390 | Analysis of nucleotides 13-96 of the human parainfluenza virus type 3 antigenomic promoter reveals positive- and negative-acting replication elements |
| Q39601579 | Analysis of the noncoding regions of measles virus strains in the Edmonston vaccine lineage |
| Q64360507 | Bipartite promoters and RNA editing of paramyxoviruses and filoviruses |
| Q42656731 | Characterization of human rabies virus vaccine strain in China |
| Q34364626 | Chemical modification of nucleotide bases and mRNA editing depend on hexamer or nucleoprotein phase in Sendai virus nucleocapsids |
| Q39774824 | Comparative and mutational analyses of promoter regions of rinderpest virus |
| Q35802939 | Competition between the Sendai virus N mRNA start site and the genome 3'-end promoter for viral RNA polymerase |
| Q42649251 | Completion of the sequence of a cetacean morbillivirus and comparative analysis of the complete genome sequences of four morbilliviruses |
| Q40723718 | Conserved and non-conserved regions in the Sendai virus genome: evolution of a gene possessing overlapping reading frames |
| Q21090169 | Cryo-electron tomography of Marburg virus particles and their morphogenesis within infected cells |
| Q36736673 | Crystal Structure of the Measles Virus Nucleoprotein Core in Complex with an N-Terminal Region of Phosphoprotein |
| Q34456557 | Distinct and overlapping roles of Nipah virus P gene products in modulating the human endothelial cell antiviral response |
| Q33933216 | Evidence that the polymerase of respiratory syncytial virus initiates RNA replication in a nontemplated fashion. |
| Q42945480 | Evidence that the respiratory syncytial virus polymerase is recruited to nucleotides 1 to 11 at the 3' end of the nucleocapsid and can scan to access internal signals |
| Q36395831 | Forty-five years of Marburg virus research |
| Q41458643 | Full genome sequence of peste des petits ruminants virus, a member of the Morbillivirus genus. |
| Q45394545 | Full genome sequences of two virulent strains of peste-des-petits ruminants virus, the Côte d'Ivoire 1989 and Nigeria 1976 strains |
| Q33806735 | Functional analysis of the genomic and antigenomic promoters of human respiratory syncytial virus. |
| Q35000130 | Given the opportunity, the Sendai virus RNA-dependent RNA polymerase could as well enter its template internally |
| Q38732930 | How order and disorder within paramyxoviral nucleoproteins and phosphoproteins orchestrate the molecular interplay of transcription and replication |
| Q42021625 | Human parainfluenza virus type 3 (HPIV-3): construction and rescue of an infectious, recombinant virus expressing the enhanced green fluorescent protein (EGFP). |
| Q33782234 | Identification of internal sequences in the 3' leader region of human respiratory syncytial virus that enhance transcription and confer replication processivity |
| Q45730246 | Identification of mutations associated with attenuation of virulence of a field Sendai virus isolate by egg passage |
| Q26851684 | Initiation and regulation of paramyxovirus transcription and replication |
| Q40475347 | Mapping of the RNA promoter of Newcastle disease virus. |
| Q38752644 | Mapping the evolutionary trajectories of morbilliviruses: what, where and whither |
| Q34328895 | Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone |
| Q40097576 | Non-encapsidated 5' copy-back defective-interfering genomes produced by recombinant measles viruses are recognized by RIG-I and LGP2 but not MDA5. |
| Q33836020 | Nucleocapsid incorporation into parainfluenza virus is regulated by specific interaction with matrix protein |
| Q27468732 | Organization, Function, and Therapeutic Targeting of the Morbillivirus RNA-Dependent RNA Polymerase Complex |
| Q24531423 | Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited |
| Q39011481 | Polymerases of paramyxoviruses and pneumoviruses |
| Q40663332 | Positive- and negative-acting signals combine to determine differential RNA replication from the paramyxovirus simian virus 5 genomic and antigenomic promoters |
| Q39549066 | RNA replication for the paramyxovirus simian virus 5 requires an internal repeated (CGNNNN) sequence motif |
| Q33840469 | Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3. |
| Q36088161 | Recombinant human parainfluenza virus type 2 vaccine candidates containing a 3' genomic promoter mutation and L polymerase mutations are attenuated and protective in non-human primates. |
| Q40572156 | Recovery of human metapneumovirus from cDNA: optimization of growth in vitro and expression of additional genes |
| Q39548712 | Regulation of RNA synthesis by the genomic termini of vesicular stomatitis virus: identification of distinct sequences essential for transcription but not replication |
| Q45398136 | Response to "Non-segmented negative-strand RNA virus RNA synthesis in vivo". |
| Q41855694 | Role for the paramyxovirus genomic promoter in limiting host cell antiviral responses and cell killing |
| Q41901075 | Roles of human parainfluenza virus type 3 bases 13 to 78 in replication and transcription: identification of an additional replication promoter element and evidence for internal transcription initiation |
| Q40740869 | Sequence analysis of the Washington/1964 strain of human parainfluenza virus type 1 (HPIV1) and recovery and characterization of wild-type recombinant HPIV1 produced by reverse genetics |
| Q42641219 | Sequence of the nucleocapsid gene and genome and antigenome promoters for an isolate of porpoise morbillivirus |
| Q33802308 | Specific phosphorylated forms of glyceraldehyde 3-phosphate dehydrogenase associate with human parainfluenza virus type 3 and inhibit viral transcription in vitro |
| Q36346815 | Structural disorder within the replicative complex of measles virus: functional implications |
| Q40502565 | The Ebola virus genomic replication promoter is bipartite and follows the rule of six. |
| Q47550214 | The control of paramyxovirus genome hexamer length and mRNA editing |
| Q37157191 | The marburg virus 3' noncoding region structurally and functionally differs from that of ebola virus |
| Q38510112 | The paramyxovirus polymerase complex as a target for next-generation anti-paramyxovirus therapeutics |
| Q33648959 | Transcript initiation and 5'-end modifications are separable events during vesicular stomatitis virus transcription. |
| Q36499709 | Unravelling the complexities of respiratory syncytial virus RNA synthesis. |
| Q39550387 | Virus promoters determine interference by defective RNAs: selective amplification of mini-RNA vectors and rescue from cDNA by a 3' copy-back ambisense rabies virus |
Search more.